Sparse, poor evidence supports fumarates for psoriasis

Even though fumaric acid esters are increasingly considered to be a suitable, even a first-line, systemic treatment for moderate to severe psoriasis in some parts of Europe, the evidence supporting their use is sparse and of low quality, according to a report published online in the British Journal...
Source: Skin and Allergy News - Category: Dermatology Source Type: news